Cargando…
Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial
BACKGROUND: Chronic pelvic pain affects 2–24% of women worldwide and evidence for medical treatments is scarce. Gabapentin is effective in treating some chronic pain conditions. We aimed to measure the efficacy and safety of gabapentin in women with chronic pelvic pain and no obvious pelvic patholog...
Autores principales: | Horne, Andrew W, Vincent, Katy, Hewitt, Catherine A, Middleton, Lee J, Koscielniak, Magda, Szubert, Wojciech, Doust, Ann M, Daniels, Jane P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527829/ https://www.ncbi.nlm.nih.gov/pubmed/32979978 http://dx.doi.org/10.1016/S0140-6736(20)31693-7 |
Ejemplares similares
-
GaPP2, a multicentre randomised controlled trial of the efficacy of gabapentin for the management of chronic pelvic pain in women: study protocol
por: Vincent, Katy, et al.
Publicado: (2018) -
Gabapentin for the Management of Chronic Pelvic Pain in Women (GaPP1): A Pilot Randomised Controlled Trial
por: Lewis, Steff C., et al.
Publicado: (2016) -
GaPP: a pilot randomised controlled trial of the efficacy of action of gabapentin for the management of chronic pelvic pain in women: study protocol
por: Horne, Andrew W, et al.
Publicado: (2012) -
Letter to the editor regarding systematic review and meta-analysis of the efficacy of gabapentin in chronic female pelvic pain without another diagnosis
por: Vincent, Katy, et al.
Publicado: (2022) -
Letter to the Editor Regarding “Gabapentin has Longer-Term Efficacy for the Treatment of Chronic Pelvic Pain in Women: A Systematic Review and Pilot Meta-analysis”
por: Vincent, Katy, et al.
Publicado: (2022)